• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Biosense Webster

18 of the world’s most innovative medical technologies

April 26, 2022 By Danielle Kirsh

Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that have received a Prix Galien award […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Diabetes, Diagnostics, Digital Health, Endoscopic, Featured, Imaging, Implants, Neuromodulation/Neurostimulation, Oncology, Orthopedics, Patient Monitoring, Replacement Heart Valves, Stents, Structural Heart Tagged With: Abbott, Alcon, Biosense Webster, Boston Scientific, Devices4Care, Diatropix, Genmab, Germitec, Hexacath, Johnson & Johnson, Medtronic, Moveo, nanobiotix, Prix Galien International, Siemens Healthineers, sysmex, The Galien Foundation, The Hubrecht Institute, Urgo Medical, VRelax

J&J wins FDA approval for ablation catheter

October 7, 2020 By Chris Newmarker

Johnson & Johnson (NYSE:JNJ) recently announced that its Biosense Webster business has secured FDA approval for its Thermocool SmartTouch SF ablation catheter. The Thermocool SmartTouch received approval for the treatment of persistent atrial fibrillation, J&J announced yesterday. Get the full story on our sister site Medical Tubing + Extrusion. 

Filed Under: Cardiovascular, Catheters, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Biosense Webster, Johnson & Johnson

These medical device companies provide the most research payments

January 31, 2020 By Danielle Kirsh

The worlds largest medical device companies are spending tens of millions of dollars a year on research payments to doctors and teaching hospitals — but the payments only make up a tiny fraction of their budgets. That was a big takeaway from an analysis of Medical Design & Outsourcing‘s annual Big 100 and the most […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Imaging, Implants, Neuromodulation/Neurostimulation, News Well, Orthopedics, Research & Development, Structural Heart, Vascular Tagged With: Abbott, becton dickinson, big data, Biosense Webster, Boston Scientific, DePuy Synthes, Ethicon, GE Healthcare, Johnson and Johnson, Medtronic, Philips, Siemens Healthineers, Stryker, Zimmer Biomet

ESC Congress 2019: Biotronik beats Abbott at target lesion failure

September 3, 2019 By Sean Whooley

Biotronik said yesterday that its Orsiro stent tops the Xience stents made by Abbott (NYSE:ABT) when it comes to target lesion failure, according to data from a clinical trial. The randomized, controlled BioSTEMI trial was the first direct comparison between the two drug-eluting stents in patients with acute ST-segment elevation myocardial infarction (STEMI). Biotronik announced […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Drug-Eluting Stents, Hospital Care, Implants, News Well, Replacement Heart Valves, Stent Grafts, Stents, Surgical Tagged With: Abiomed, atrial fibrillation, Biosense Webster, Biotronik, CABG, Carmat Inc., CellAegis Devices, European Society of Cardiology (ESC), Johnson and Johnson

Innovative Health lands another catheter reprocessing clearance

July 1, 2019 By Nancy Crotti

Innovative Health said today that it has received FDA clearance to reprocess the Biosense Webster PentaRay Nav eco high-density mapping catheter for reuse. The clearance is the latest allowing Scottsdale, Ariz.-based Innovative Health to reprocess catheters. The FDA cleared it in 2018 to reprocess St. Jude Medical’s Advisor FL, Medtronic’s Torqr and Marinr and Biosense Webster’s […]

Filed Under: Cardiovascular, Catheters, Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: Biosense Webster, FDA, Innovative Health, Medtronic, stjudemedical

HRS 2019 Roundup: Medtronic touts extravascular ICD pilot

May 13, 2019 By Brad Perriello

The pilot study of an extravascular implantable cardiac defibrillator developed by Medtronic (NYSE:MDT), which is designed to deliver both defibrillation and anti-tachycardia pacing using leads placed outside the heart and venous system, showed strong safety and efficacy results. The safety outcome for the 26-patient study, presented last week at the annual meeting of the Heart […]

Filed Under: Cardiovascular, Clinical Trials, Featured Tagged With: AFTx, Biosense Webster, Boston Scientific, Cardiac Rhythm Management, Cardiofocus, HRS 2019, Javelin Medical, Johnson and Johnson, MediLynx, Medtronic, Preventice, Spacelabs Healthcare

J&J’s Biosense Webster launches Heliostar multi-electrode ablation cath trial

November 30, 2018 By Sarah Faulkner

Johnson & Johnson‘s (NYSE:JNJ) Biosense Webster said this week that it enrolled and treated the first patient in its Stellar U.S. investigational device exemption study. The 640-patient trial is designed to assess the safety and efficacy of the Heliostar multi-electrode radiofrequency balloon ablation catheter as a treatment for drug refractory recurrent paroxysmal atrial fibrillation. The […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Featured, Vascular, Wall Street Beat Tagged With: Biosense Webster, Johnson and Johnson

FDA clears Innovative Health to reprocess major manufacturers’ catheters

November 29, 2018 By Nancy Crotti

Innovative Health said it has nabbed FDA clearances to reprocess diagnostic catheters made by St. Jude Medical, Medtronic and Biosense Webster. The catheters include St. Jude Medical’s Advisor FL, Medtronic’s Torqr and Marinr and Biosense Webster’s Decanav. Innovative Health said it is the first in the industry to receive clearances to reprocess the Advisor and the Decanav, […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Food & Drug Administration (FDA) Tagged With: Biosense Webster, FDA, innovativehealth, Medtronic, stjudemedical

Stereotaxis, J&J’s BioSense Webster extend deal for magnetic ablation catheters

June 25, 2018 By Fink Densford

Stereotaxis (NSDQ:STXS) said today it extended a long-term deal with Johnson & Johnson’s (NYSE:JNJ) Biosense Webster to supply it with magnetic ablation catheters. With the extended deal, St. Louis-based Stereotaxis said it will continue to supply Biosense Webster’s catheters, and will continue to receive a royalty for the sale of those catheters. The deal includes Biosense Webster’s Navistar […]

Filed Under: Business/Financial News, Catheters Tagged With: Biosense Webster, Johnson and Johnson, Stereotaxis

HRS 2018 Roundup: Researchers highlight the latest in cardiac ablation tech

May 14, 2018 By Sarah Faulkner

There are lots of new opportunities in ablation, evidenced by the research touted at this year’s annual meeting of the Heart Rhythm Society in Boston. Scientists presented data from trials evaluating cardiac ablation via pulsed electric fields, intramural needle ablation and more. Editors at MassDevice.com asked leading cardiac electrophysiologist Dr. Vivek Reddy, will there someday be one […]

Pages: Page 1 Page 2 Page 3 Page 4

Filed Under: Cardiovascular, Clinical Trials, Wall Street Beat Tagged With: Biosense Webster, Boston Scientific, Johnson and Johnson, Medtronic

J&J’s Biosense Webster launches Carto Vizigo guiding sheath

May 8, 2018 By Fink Densford

Johnson & Johnson’s (NYSE:JNJ) Biosense Webster said yesterday it launched its Carto Vizigo bi-directional guiding sheath designed for use with the company’s Carto 3 system in the US. The Irvine, Calif.-based division said that the sheath is designed for use with the Carto 3 system during catheter ablation procedures to aid electrophysiologists in reducing fluoroscopy dependency and […]

Filed Under: Business/Financial News, Catheters Tagged With: Biosense Webster, Johnson and Johnson

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS